NCT Number: NCT01342783
Biomarkers in Samples From Young Patients With Soft Tissue Sarcoma
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.
PURPOSE: This research trial is studying biomarkers in samples from young patients with soft tissue sarcoma.
Looking for future studies?
Notify MeKey information
Age range
Up to 18 year
Sex eligibility
All sexes
Study type
Observational
About this study
OBJECTIVES:
- To identify the key components of driver pathways of primary and secondary soft tissue sarcomas.
- To perform the next-generation sequencing on primary versus normal on undifferentiated sarcomas.
OUTLINE: Genomic DNA and RNA samples from undifferentiated sarcoma tumors are analyzed by next-generation sequencing for somatic mutations. Normal matched lymphocytes and tissue are also analyzed.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
- Banked childhood samples from the COG-D9902 soft tissue sarcoma biology and banking study
- Rhabdomyosarcoma, NOS
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Treatment and study plan
RNA analysis
Geneticmutation analysis
Geneticnucleic acid sequencing
Geneticlaboratory biomarker analysis
OtherPrimary outcomes
-
Occurrence of somatic mutations in driver genes and mutations in other genes that occur individually
Sponsors and collaborators
Lead sponsor
Children's Oncology Group
Network
Collaborators
- National Cancer Institute (NCI)
Registry information
Official study title
Next Generation Sequencing of Childhood Soft Tissue Sarcomas to Identify Drivers of Primary and Metastatic Disease
Important dates
- Study start
- 2011
- Primary completion
- 2016
- First posted
- Apr 27, 2011
- Registry last updated
- May 18, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors
NCT01875601
Brain Diseases, Brain Neoplasms
Bethesda, Maryland, United States
View Trial DetailsA Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
NCT05708950
Adnexal Diseases, Breast Cancer
Santa Monica, California, United States
View Trial DetailsThe Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors
NCT07651020
Adnexal Diseases, Astrocytoma
Wuhan, Hubei, China
View Trial DetailsChidamide Combined With Toripalimab in Sarcoma
NCT04025931
Neoplasms, Neoplasms by Histologic Type
Guangzhou, Guangdong, China
View Trial Details